1. POSITION VACANT: Phlebotomist, Navi Mumbai, SAMS (TCV Project Managed by WHO India, CDC USA and Stanford University, USA).
2. PROJECT BACKGROUND:
The Navi Mumbai Municipal Corporation (NMMC) is introducing Typhoid Conjugate Vaccine (TCV) in its routine immunisation (RI) programme, commencing with phased vaccination programme from 2018 onwards. Introduction of TCV will provide an opportunity to estimate the burden of typhoid in NMMC and evaluate the effectiveness of the vaccine in public health settings.